Finance

Beta
Lists
1MDGL:BIT
Madrigal Pharmaceuticals Inc
€412.50
-3.03%
(-12.90) 1D
May 11, 10:59:00 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1MDGL...
Mkt. cap
11.23B
Avg. vol.
1.00
Volume
0.00
52-wk high
€518.20
52-wk low
€241.60
No. of employees
915
Mkt. cap
11.23B
Avg. vol.
1.00
Volume
0.00
52-wk high
€518.20
52-wk low
€241.60
No. of employees
915
News stories
From sources across the web
About Madrigal Pharmaceuticals Inc
CEOPaul A. Friedman
Employees915
Founded2011
HeadquartersWest Conshohocken, Pennsylvania, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
212.80M
287.27M
321.08M
311.34M
Cost of goods sold
9.06M
18.12M
24.45M
26.85M
Cost of revenue
9.06M
18.12M
24.45M
26.85M
Research and development expenses
54.08M
174.00M
116.27M
108.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
196.86M
209.12M
239.98M
268.52M
Operating expense
250.94M
383.12M
356.24M
377.21M
Total operating expenses
260.00M
401.24M
380.69M
404.06M
Operating income
-47.20M
-113.98M
-59.61M
-92.72M
Other non operating income
-42.00K
-293.00K
-128.00K
-
EBT including unusual items
-42.28M
-114.19M
-58.58M
-94.39M
EBT excluding unusual items
-42.28M
-111.41M
-58.58M
-94.39M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-42.28M
-114.19M
-58.58M
-94.39M
Net profit margin
-19.87%
-39.75%
-18.24%
-30.32%
Earnings per share
-1.90
-4.96
-2.57
-1.38
Interest and investment income
8.23M
10.31M
9.46M
8.24M
Interest expense
-3.26M
-7.45M
-8.30M
-7.82M
Net interest expenses
4.96M
2.86M
1.16M
424.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-46.82M
-113.62M
-59.22M
-92.34M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more